Insider Purchases: Inside the Buy
Tag: dividend growth stocks
🫀 Boston Scientific (BSX): A GARP Reset on a Medical Device Powerhouse
Boston Scientific stock has fallen nearly 48% from its highs, but the business engine remains strong. With double-digit revenue growth, major cardiovascular catalysts, director insider buying, low short interest, and a $2B buyback, BSX may be one of the cleaner large-cap healthcare GARP setups on the market.
Badger Meter (BMI) Stock Analysis 2026: Insider Buys After 24% Crash 💧📉
Badger Meter just took a 24% hit—but the CEO is buying the dip. With strong long-term water infrastructure trends and improved valuation, is BMI a hidden opportunity or just treading water?
Quick links
Search
Privacy Policy
Refund Policy
Shipping Policy
Terms of Service
Contact us
About us
FUNanc!al distills the fun in finance and the finance in fun, makes news personal, and helps all reach happiness.
